Creso Pharma Ltd
ASX:CPH

Watchlist Manager
Creso Pharma Ltd Logo
Creso Pharma Ltd
ASX:CPH
Watchlist
Price: 0.008 AUD Market Closed
Market Cap: 17.7m AUD

Relative Value

There is not enough data to reliably calculate the relative value of CPH.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CPH Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
2
Median 5Y
2
Industry
2.7
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.6
Industry
21.6
vs History
vs Industry
Median 3Y
-1
Median 5Y
-1.2
Industry
16.9
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.5
Industry
22.9
vs History
vs Industry
Median 3Y
2
Median 5Y
2
Industry
2.3
vs History
vs Industry
Median 3Y
1.9
Median 5Y
1.9
Industry
3
vs History
vs Industry
Median 3Y
45.5
Median 5Y
45.5
Industry
5.6
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
13.4
vs History
vs Industry
Median 3Y
-0.9
Median 5Y
-0.9
Industry
16.7
vs History
vs Industry
Median 3Y
-1
Median 5Y
-1.1
Industry
16.1
vs History
vs Industry
Median 3Y
-1
Median 5Y
-1.1
Industry
18.9
vs History
vs Industry
Median 3Y
0.9
Median 5Y
0.9
Industry
2

Multiples Across Competitors

CPH Competitors Multiples
Creso Pharma Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Creso Pharma Ltd
ASX:CPH
17.7m AUD 2 -0.5 -0.9 -0.9
US
Eli Lilly and Co
NYSE:LLY
982.7B USD 16.5 53.4 35.8 38.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
528.3B USD 5.7 21 17.2 22.3
CH
Roche Holding AG
SIX:ROG
276B CHF 4.5 29.3 12.4 14.5
UK
AstraZeneca PLC
LSE:AZN
218.7B GBP 5 31.1 108.4 158.7
CH
Novartis AG
SIX:NOVN
220B CHF 4.9 19 12 15.6
US
Merck & Co Inc
NYSE:MRK
273.7B USD 4.3 14.4 10.2 12.1
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK 5.4 16.3 11.4 13.2
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
146.1B USD 2.3 14.9 7.5 10.3
P/E Multiple
Earnings Growth PEG
AU
Creso Pharma Ltd
ASX:CPH
Average P/E: 24.9
Negative Multiple: -0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.4
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
21
29%
0.7
CH
Roche Holding AG
SIX:ROG
29.3
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.1
37%
0.8
CH
Novartis AG
SIX:NOVN
19
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.4
15%
1
DK
Novo Nordisk A/S
CSE:NOVO B
16.3
3%
5.4
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
Creso Pharma Ltd
ASX:CPH
Average EV/EBITDA: 440
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.8
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
17.2
9%
1.9
CH
Roche Holding AG
SIX:ROG
12.4
5%
2.5
UK
AstraZeneca PLC
LSE:AZN
108.4
10%
10.8
CH
Novartis AG
SIX:NOVN
12
6%
2
US
Merck & Co Inc
NYSE:MRK
10.2
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11.4
1%
11.4
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.5
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
Creso Pharma Ltd
ASX:CPH
Average EV/EBIT: 1 883.7
Negative Multiple: -0.9
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.4
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
22.3
15%
1.5
CH
Roche Holding AG
SIX:ROG
14.5
6%
2.4
UK
AstraZeneca PLC
LSE:AZN
158.7
23%
6.9
CH
Novartis AG
SIX:NOVN
15.6
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12.1
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5